NU-MED PLUS, INC. (OTCMKTS:NUMD) Files An 8-K Unregistered Sales of Equity SecuritiesItem 3.02 Unregistered Sales of Equity Securities.
On September 8, 2017, we completed a Stock Purchase Agreement with Smith Corporate Services, Inc. (SCS) for 1,600,000 shares of common stock at $0.25 per share for a total purchase price of $400,000. We received $45,000 for the initial issuance of 180,000 shares of our common stock to SCS. The remaining balance of the purchase price, $355,000, may be purchased at any time and in any quantity until August 30, 2018, when the Stock Purchase Agreement will terminate and SCS will no longer be able to purchase the balance of shares. A copy of the completed Stock Purchase Agreement is attached in Item 9.01.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
Exhibit Table #
Title of Document
Location
10.1
Stock Purchase Agreement
This Filing
Nu-Med Plus, Inc. Exhibit…To view the full exhibit click here
About NU-MED PLUS, INC. (OTCMKTS:NUMD)
NU-MED PLUS, INC. (NU-MED) is an early stage company, which is engaged in developing, manufacturing and marketing technologies in the medical device field. The Company intends to become a medical device company principally engaged in the design, development, enhancement and commercialization of beginning, early, and selective later-stage medical devices. The Company focuses on the creation of a nitric oxide powder formulation, a hospital bedside nitric oxide generator and a mobile rechargeable device to deliver nitric oxide gas to offer solutions to hospitals, health systems and the medical community around the world. NU-MED has developed a prototype lightweight Portable NO Delivery System that can be worn by patients outside of the hospital setting for underserved chronic therapies, and for applications within the United States and in developing nations. The Company has not generated any revenues.
